CLINICAL_TRIALS
trial_result
· 2024-04-22
Clinical Trial Update: Phase IIa, Randomized, Double Blinded, Placebo Controlled, Dose Finding Study for TLC599 in OA Patients [Phase 2]
Summary
Phase IIa randomized, double-blind, placebo-controlled dose-finding trial of TLC599 in osteoarthritis of the knee has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Taiwan Liposome Company | Conditions: Osteoarthritis of the Knee | Phase 2 | Status: COMPLETED | Results posted: 2024-04-22